The chart below shows how ELMD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ELMD sees a -4.66% change in stock price 10 days leading up to the earnings, and a -0.49% change 10 days following the report. On the earnings day itself, the stock moves by +1.07%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Net Revenue Increase: Net revenues grew 19.0% to $14.7 million from $12.3 million in Q1 FY 2024.
Direct Home Care Revenue Growth: Revenue in our direct home care business increased year-over-year by 18.5% to $13.2 million from $11.2 million in the year prior.
Gross Profit Improvement: Gross profit increased to $11.5 million or 78.3% of net revenues from $9.5 million or 77.1% of net revenues in Q1 FY 2024.
Operating Income Increase: Operating income was $1.9 million or 13.2% of revenue compared to $0.1 million or 1.2% of revenue in the first quarter last year.
Net Income and EPS: Net income of $1.5 million and quarterly EPS for our shareholders of $0.16 per diluted share.
Negative
Operating Income Increase: Operating income was $1.9 million or 13.2% of revenue compared to $0.1 million or 1.2% of revenue in the first quarter last year.
SG&A Expense Increase: Selling, general, and administrative expenses were $9.4 million, representing an increase of $0.2 million or 2.6% compared to Q1 FY 2024.
Payroll Expense Increase: Payroll and compensation-related expenses increased by $691,000 or 12.0% to $6.5 million.
R&D Expense Reduction: Research and development expenses decreased by $40,000 or 19.4% to $166,000.
Decrease in Professional Fees: Professional fees decreased by $171,000 or 13.0% to $1,140,000.
Electromed, Inc. (ELMD) Q1 2025 Earnings Call Transcript
ELMD.A
-1.15%